SpyGlass Pharma Income Statement (2025-2026) | SGP

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2025 Jun2026
Shares Outstanding (Entity) (Quarter) 33.45M
Operating items
Research & Development (Quarter) 7.33M10.94M
Selling, General & Administrative (Quarter) 1.96M11.03M
Operating Expenses (Quarter) 9.30M21.97M
Operating Income (Quarter) -9.30M-21.97M
EBIT (Quarter) -9.30M-21.97M
Additional items
Shares Outstanding (Quarter) 33.44M
Shares Outstanding (Diluted) (Quarter) 33.44M
Interest Expenses (Quarter) 65.55M
EPS (Basic) (Quarter) -0.39-0.59
EPS (Diluted) (Quarter) -3.81-0.59
EBITDA (Quarter) -9.30M-21.97M
Non-operating items
Interest & Investment Income (Quarter) 0.62M2.10M
Non Operating Income (Quarter) 0.62M2.10M
Net income details
EBT (Quarter) -8.68M-19.86M
Profit After Tax (Quarter) -8.68M-19.86M
Income from Continuing Operations (Quarter) -8.68M-19.86M
Consolidated Net Income (Quarter) -8.68M-19.86M
Income towards Parent Company (Quarter) -8.68M-19.86M
Net Income towards Common Stockholders (Quarter) -8.68M-19.86M